Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Clinical trial NCT04331067 · TERMINATED
Trial details
- NCT number
- NCT04331067
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-19
- Primary completion
- 2023-03-20
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.